Publications of Y. Genzel
All genres
Talk (105)
221.
Talk
Characterization of flow conditions in wave bioreactors using CFD. 7th European Symposium on Biochemical Engineering Science – ESBES-7, Faro, Portugal (2008)
222.
Talk
Influenza and modified vaccinia Ankara (MVA) production in avian designer cells. Bioperspectives, Hannover, Germany (2008)
223.
Talk
Virus-host cell interactions in a vaccine production process: Proteomic analysis of influenza A virus infected mammalian cells by 2D-DIGE. Proteomics Europe, Lisboa, Portugal (2008)
224.
Talk
Metabolic flux model for an adherent MDCK cellline: Comparison of flux distributions under different cultivation conditions. Dynamic Systems in Practice Focus : Systems Biology, Magdeburg, Germany (2008)
225.
Talk
Vero or MDCK cells for influenza A virus production in microcarrier systems? European BioPerspectives 2007, Cologne, Germany (2007)
226.
Talk
Implementation of analytical methods during upstream processing for an influenza A virus production process. Vaccine Production : Analytical Methods, Characterisation, Scale-up and Manufacturing, Cologne, Germany (2007)
227.
Talk
Lectin-affinity chromatography: a novel purification method for cell culture based Influenza vaccine production from the current season 2006/07. European BioPerspectives 2007, Cologne, Germany (2007)
228.
Talk
Lektin-Affinitätschromatographie - Neuartige Methode zur Aufreinigung humaner Influenza Viren aus Zellkulturen zur Impfstoffproduktion. DECHEMA/GVC Vortrag- und Diskussionstagung "Aufarbeitung biotechnologischer Produkte", Osnabrück, Germany (2007)
229.
Talk
Efficient influenza virus capture from cell cultivation broth by a novel affinity chromatography. AIChE Annual meeting 2007, Salt Lake City, USA (2007)
230.
Talk
Novel capturing method for currently spread influenza viruses from cell cultures by affinity separation. ISPPP 2007, Orlando, USA (2007)
231.
Talk
Quantitative proteomic analysis of influenza A virus infected mammalian cells: Elucidation of virus / host cell interactions with respect to the vaccine production process. 27th International Symposium & Exhibit on the Separation of Proteins, Peptides & Polynucleotides (ISPPP 2007), Orlando, USA (2007)
232.
Talk
Metabolite Analysis in Mammalian Cells: How to generate reliable data sets? 20th ESACT meeting, Dresden, Germany (2007)
233.
Talk
Characterization and analytical issues on an influenza A virus production process. Vaccines : Quality control, scale-up and manufacture, Hamburg, Germany (2006)
234.
Talk
Production of vaccines based on animal cell technology. Production of Biopharmaceuticals in Animal Cell Cultures, Rio de Janeiro, Brazil (2006)
235.
Talk
Limits and benefits of the interpretation of extracellular metabolite data in mammalian cell culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)
236.
Talk
Neue Zellsubstrate und Einfluss von Medien und Prozessführung in der Impfstoffproduktion. 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
237.
Talk
High Cell Density Microcarrier Process in a Wave Bioreactor for the Production of Influenza A Virus. Vaccine Technology, Puerto Vallarta, Mexiko (2006)
238.
Talk
A generic purification scheme for the production of human influenza vaccines derived from serum-free mammalian cell culture. Vaccine Technology, Puerto Vallarta, Mexico (2006)
239.
Talk
Chromatography-based purification of influenza A virus for the production of human whole-virion vaccines. ISPPP 2006 : 26th International Symposium on the Separation of Proteins, Peptides and Polynucleotides, Innsbruck, Austria (2006)
240.
Talk
Monitoring Energy Metabolism: The Challenge of Intracellular Metabolite Analysis of Mammalian Cells in Culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)